华宝医药生物混合C(019029)资产配置
| 序号 |
报告期 |
股票占净比(%) |
债券占净比(%) |
现金占净比(%) |
净资产(元) |
| 1 |
2025-12-31 |
86.23 |
- |
13.30 |
536,221,472.06 |
| 2 |
2025-09-30 |
91.59 |
- |
13.50 |
629,094,768.96 |
| 3 |
2025-06-30 |
89.17 |
- |
16.31 |
521,185,417.08 |
| 4 |
2025-03-31 |
90.94 |
- |
9.50 |
606,103,655.91 |
| 5 |
2024-12-31 |
84.80 |
- |
11.97 |
544,446,467.60 |
| 6 |
2024-09-30 |
93.99 |
- |
6.48 |
870,758,362.50 |
| 7 |
2024-06-30 |
88.40 |
- |
12.08 |
855,474,154.63 |
| 8 |
2024-03-31 |
91.51 |
- |
11.67 |
1,158,488,226.63 |
| 9 |
2023-12-31 |
91.20 |
- |
8.66 |
1,342,848,485.88 |
| 10 |
2023-09-30 |
80.48 |
- |
9.68 |
768,236,226.51 |
欢迎访问证券之星！请点此与我们联系 版权所有： Copyright © 1996-年
微信公众号
证券之星APP
基本资料
